Navigation Links
Forest Laboratories' Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
Date:10/2/2007

Doctors Disagree Over Which Drugs Are More Effective, According to a New

Report from Decision Resources

WALTHAM, Mass., Oct. 1 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Forest Laboratories' Lexapro and generics- dominated fluoxetine lead first-line therapy in the treatment of major depression. According to the new report entitled Treatment Algorithms in Major Depression, selective serotonin reuptake inhibitors (SSRIs), which include Lexapro and Prozac, account for 63.6 percent of patients on first-line therapy. Surveyed physicians indicate the reasons for SSRIs being so heavily used are efficacy, cost and physician familiarity. Eighty percent of surveyed psychiatrists and seventy percent of surveyed primary-care physicians (PCPs) said the reason why they chose SSRIs over benzodiazepines is efficacy. The major reason 49 percent of surveyed psychiatrists chose SSRIs over serotonin/norepinephrine reuptake inhibitors (SNRIs) is cost, while 49 percent of PCPs say they chose SSRIs over SNRIs owing to familiarity with the former class.

The report also finds that psychiatrists and PCPs do not all agree on what the most effective drugs are for treatment of major depression; therefore there is significant variation in the choice of agents, with no clear dominant player. Forty four percent of surveyed PCPs say SSRIs are more effective than SNRIs, but 72 percent of psychiatrists believe the opposite. Sixty two percent of surveyed PCPs think Lexapro's efficacy against depression is a major reason to choose it, but only 24 percent of surveyed psychiatrists agree.

"We project a significant increase in the use of SNRIs in first-line therapy in the next two years," said Michael Malecki, Ph.D., analyst at Decision Resources. "Forty five percent of surveyed psychiatrists and forty eight percent of surveyed PCPs say they will mor
'/>"/>

SOURCE Decision Resources
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. DeForest biodiesel plant begins production
2. Biodiesel plant being built in DeForest to make alternative fuel
3. Use of X-rays to advance wood-decay knowledge leads to honor for Forest Products Lab biologist
4. Biodiversity threatened as forests become islands of green, UW professor says
5. BioRobot MDx standardize your automated protocols in clinical laboratories
6. Distance-Learning Remote Laboratories using LabVIEW
7. States are the best laboratories for healthcare reform
8. Scientific Protein Laboratories Acquired by New York firm
9. The Genesis of Gendicine: The Story Behind the First Gene Therapy
10. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
11. TomoTherapy opens technical training center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... ... August 05, 2015 , ... InSphero AG , ... organotypic 3D cell culture models, announced today that its patented GravityPLUS™ Hanging ... now available for purchase exclusively through PerkinElmer.     , InSphero will now broaden global ...
(Date:8/5/2015)... (PRWEB) , ... August 05, 2015 , ... ... to aid the transition from legacy tubes, with 2D barcode labels on the ... decodes 100 legacy tube 2D barcodes in 1 second, using FluidX’s IntelliCode software, ...
(Date:8/5/2015)... ... August 05, 2015 , ... MTI-GlobalStem, a leading supplier ... an updated corporate identity, including new company name, logo and website. GlobalStem was ... company moved into a new, joint facility in 2014 to bring the two ...
(Date:8/4/2015)... ... August 05, 2015 , ... Spirax Sarco , Inc. ... line.” The handbook provides a complete range of information needed to evaluate ... standard product offering into an easy-to-navigate single edition,” says Dawn Dukes, Public Relations ...
Breaking Biology Technology:InSphero Expands Global Availability of its Patented 3D Cell Culture Platforms 2InSphero Expands Global Availability of its Patented 3D Cell Culture Platforms 3RURO Announces FreezerPro® 7 Integration with Top-down 2D barcode scanners by FluidX 2MTI-GlobalStem Announces Updated Company Identity and Website 2MTI-GlobalStem Announces Updated Company Identity and Website 3Spirax Sarco releases Product Handbook 2
... Entire Project Information, CAMBRIDGE, England and ... plc (LSE: AU. or AU.L), a,global leader ... that Extract Technology, a leading supplier of ... markets, has,implemented its Meridio records management solution ...
... PXS; Nasdaq: PXSL) today announced the appointment of ... of directors., Mr Delaat has 35 years ... the managing director of the Australian,subsidiary of Merck ... until his recent,retirement., During his career Mr ...
... has developed a technique that controls the number of ... considered impossible for the past two decades. , Led ... potassium atoms onto the surface of a piece of ... continuously manipulate the number of electrons on ultra-thin layers ...
Cached Biology Technology:Autonomy Meridio Enables Extract Technology to Enhance Capabilities in Compliance With Manufacturing Regulations 2Autonomy Meridio Enables Extract Technology to Enhance Capabilities in Compliance With Manufacturing Regulations 3Autonomy Meridio Enables Extract Technology to Enhance Capabilities in Compliance With Manufacturing Regulations 4New Pharmaxis Board Appointment 2UBC physicists develop 'impossible' technique to study and develop superconductors 2
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 /PRNewswire/ ... ( http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition ... Component (Hardware, Software, and Service), Sub-Segment (Computer ... Cloud Forensics), Tool Types, Service, Vertical and ... report to their offering. By ...
(Date:8/4/2015)... 4, 2015  AMRI (NASDAQ: AMRI ) today reported financial ... Highlights: , Second quarter contract revenue of ... , Adjusted contract margins of 26 ... including a $0.05 decrease in EPS from royalties in the current ... "We are very pleased to present another strong ...
(Date:8/3/2015)... Calif. , Aug. 3, 2015 Synaptics, ... human interface solutions, today announced that members of the ... at the Pacific Crest Global Technology Leadership Forum on ... The conference will be held at the Sonnenalp Resort ... The presentation may include forward-looking information. An audio ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
... games, pioneering gene therapies and new medical devices are ... from the Department of Health and the Wellcome Trust. ... Health Innovation Challenge Fund, which was set up in ... with potential clinical application in the NHS within a ...
... University of Nottingham have opened the way for more ... infections by proving a long-held theory about how bacteria ... School of Molecular Medical Sciences have shown for the ... method, a process called ,quorum sensing, directly depends on ...
... PITTSBURGH, May 17, 2012 A change in the formulation ... may make it safer to use in the rectum, suggests ... of Antimicrobial Chemotherapy. In laboratory tests of rectal ... the reformulated gel was less harmful to the lining of ...
Cached Biology News:NHS set to benefit from UK-led technologies 2NHS set to benefit from UK-led technologies 3Fighting bacteria's strength in numbers 2Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use 2Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use 3
Human interferon-beta (IFN-beta). Recognizes amino acids 30-47 of IFN-beta. No cross-reactivity with Human IFN-alpha or IFN-gamma....
... in Refrigerated Vapor Trap Models RVT100, RVT400, ... Models UVS400, UVS400A and UVS800DDA., A non-corrosive, ... use for temperatures ranging from -105 to ... stability and does not evaporate. Far superior ...
Acetate Plate Sealers 100/Box...
... of proteomics demands the detection of very ... of the AXIMA-CFRplus with improved resolution (20,000) ... provides increased confidence in protein identification. The ... sensitivity, automated sample target handling and the ...
Biology Products: